Huapont Life SciencesLtd Balance Sheet Health
Financial Health criteria checks 5/6
Huapont Life SciencesLtd has a total shareholder equity of CN¥16.8B and total debt of CN¥9.6B, which brings its debt-to-equity ratio to 57.2%. Its total assets and total liabilities are CN¥31.5B and CN¥14.7B respectively. Huapont Life SciencesLtd's EBIT is CN¥1.4B making its interest coverage ratio -350.6. It has cash and short-term investments of CN¥4.9B.
Key information
57.2%
Debt to equity ratio
CN¥9.60b
Debt
Interest coverage ratio | -350.6x |
Cash | CN¥4.90b |
Equity | CN¥16.78b |
Total liabilities | CN¥14.70b |
Total assets | CN¥31.48b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002004's short term assets (CN¥12.2B) exceed its short term liabilities (CN¥11.3B).
Long Term Liabilities: 002004's short term assets (CN¥12.2B) exceed its long term liabilities (CN¥3.4B).
Debt to Equity History and Analysis
Debt Level: 002004's net debt to equity ratio (28%) is considered satisfactory.
Reducing Debt: 002004's debt to equity ratio has reduced from 82.3% to 57.2% over the past 5 years.
Debt Coverage: 002004's debt is not well covered by operating cash flow (17.9%).
Interest Coverage: 002004 earns more interest than it pays, so coverage of interest payments is not a concern.